Literature DB >> 33498940

Proteomic Analysis of the Secretome and Exosomes of Feline Adipose-Derived Mesenchymal Stem Cells.

Antonio J Villatoro1,2, María Del Carmen Martín-Astorga1, Cristina Alcoholado1, María Del Mar Sánchez-Martín1, José Becerra1,3,4.   

Abstract

Mesenchymal stem cells (MSCs) have been shown to have therapeutic efficacy in different complex pathologies in feline species. This effect is attributed to the secretion of a wide variety of bioactive molecules and extracellular vesicles, such as exosomes, with significant paracrine activity, encompassed under the concept of the secretome. However, at present, the exosomes from feline MSCs have not yet been studied in detail. The objective of this study is to analyze and compare the protein profiles of the secretome as a whole and its exosomal fraction from feline adipose-derived MSCs (fAd-MSCs). For this, Gene Ontology (GO), Kyoto Encyclopedia of Genes and Genomes (KEGG) and Protein-Protein Interaction Networks Functional Enrichment Analysis (STRING) were utilized. A total of 239 proteins were identified in the secretome, and 228 proteins specific to exosomes were identified, with a total of 133 common proteins. The proteins identified in the secretome were located in the extracellular regions and in the cytoplasm, while the exosomal proteins were located mainly in the membrane, cytoplasm and cytosol. Regarding function, in the secretome, proteins involved in different metabolic pathways, in pathways related to the immune system and the endocrine system and in the processing of proteins in the endoplasmic reticulum predominated. In contrast, proteins specific to exosomes were predominantly associated with endocytosis, cell junctions, platelet activation and other cell signaling pathways. The possible future use of the secretome, or some of its components, such as exosomes, would provide a non-cell-based therapeutic strategy for the treatment of different diseases that would avoid the drawbacks of cell therapy.

Entities:  

Keywords:  exosomes; feline; mesenchymal stem cells; secretome; ultrahigh-performance liquid chromatography-high-resolution mass spectrometry (UHPLC–HRMS)

Year:  2021        PMID: 33498940      PMCID: PMC7912403          DOI: 10.3390/ani11020295

Source DB:  PubMed          Journal:  Animals (Basel)        ISSN: 2076-2615            Impact factor:   2.752


  71 in total

1.  In vitro comparison of feline bone marrow-derived and adipose tissue-derived mesenchymal stem cells.

Authors:  Tracy L Webb; Jessica M Quimby; Steven W Dow
Journal:  J Feline Med Surg       Date:  2012-02       Impact factor: 2.015

Review 2.  Complement activation, regulation, and molecular basis for complement-related diseases.

Authors:  Goran Bajic; Søren E Degn; Steffen Thiel; Gregers R Andersen
Journal:  EMBO J       Date:  2015-10-21       Impact factor: 11.598

Review 3.  Immunomodulation by mesenchymal stem cells in veterinary species.

Authors:  Danielle D Carrade; Dori L Borjesson
Journal:  Comp Med       Date:  2013-06       Impact factor: 0.982

4.  Comparative analysis and characterization of soluble factors and exosomes from cultured adipose tissue and bone marrow mesenchymal stem cells in canine species.

Authors:  A J Villatoro; C Alcoholado; M C Martín-Astorga; V Fernández; M Cifuentes; J Becerra
Journal:  Vet Immunol Immunopathol       Date:  2018-12-18       Impact factor: 2.046

Review 5.  The current landscape of the mesenchymal stromal cell secretome: A new paradigm for cell-free regeneration.

Authors:  Vijay Bhaskar Reddy Konala; Murali Krishna Mamidi; Ramesh Bhonde; Anjan Kumar Das; Radhika Pochampally; Rajarshi Pal
Journal:  Cytotherapy       Date:  2015-11-26       Impact factor: 5.414

6.  Therapeutic Efficacy of Fresh, Allogeneic Mesenchymal Stem Cells for Severe Refractory Feline Chronic Gingivostomatitis.

Authors:  Boaz Arzi; Kaitlin C Clark; Ayswarya Sundaram; Mathieu Spriet; Frank J M Verstraete; Naomi J Walker; Megan R Loscar; Nasim Fazel; William J Murphy; Natalia Vapniarsky; Dori L Borjesson
Journal:  Stem Cells Transl Med       Date:  2017-06-15       Impact factor: 6.940

7.  Mechanisms utilized by feline adipose-derived mesenchymal stem cells to inhibit T lymphocyte proliferation.

Authors:  Nopmanee Taechangam; Smita S Iyer; Naomi J Walker; Boaz Arzi; Dori L Borjesson
Journal:  Stem Cell Res Ther       Date:  2019-06-25       Impact factor: 6.832

8.  Canine colostrum exosomes: characterization and influence on the canine mesenchymal stem cell secretory profile and fibroblast anti-oxidative capacity.

Authors:  Antonio J Villatoro; María Del Carmen Martín-Astorga; Cristina Alcoholado; José Becerra
Journal:  BMC Vet Res       Date:  2020-11-02       Impact factor: 2.741

Review 9.  Engineering mesenchymal stem cells to improve their exosome efficacy and yield for cell-free therapy.

Authors:  Jennifer Phan; Priyadarsini Kumar; Dake Hao; Kewa Gao; Diana Farmer; Aijun Wang
Journal:  J Extracell Vesicles       Date:  2018-09-26

10.  Comprehensive proteomic analysis of exosomes derived from human bone marrow, adipose tissue, and umbilical cord mesenchymal stem cells.

Authors:  Zheng-Gang Wang; Zhi-Yi He; Shuang Liang; Qing Yang; Peng Cheng; An-Min Chen
Journal:  Stem Cell Res Ther       Date:  2020-11-27       Impact factor: 6.832

View more
  2 in total

1.  Secretory Profile of Adipose-Tissue-Derived Mesenchymal Stem Cells from Cats with Calicivirus-Positive Severe Chronic Gingivostomatitis.

Authors:  Antonio J Villatoro; María Del Carmen Martín-Astorga; Cristina Alcoholado; Liliya Kazantseva; Casimiro Cárdenas; Fernando Fariñas; José Becerra; Rick Visser
Journal:  Viruses       Date:  2022-05-25       Impact factor: 5.818

2.  Adipose stem cells-released extracellular vesicles as a next-generation cargo delivery vehicles: a survey of minimal information implementation, mass production and functional modification.

Authors:  Jianguo Chen; Ruiquan Liu; Tianyu Huang; Hengyun Sun; Haiyue Jiang
Journal:  Stem Cell Res Ther       Date:  2022-05-03       Impact factor: 8.079

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.